Folate Receptor Alpha Dendritic Cells (FRαDCs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Folate Receptor Alpha Dendritic Cells (FRαDCs), covering 2025-10-02 to 2025-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial [Phase 2]